Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
F. Hoffmann-La Roche: Alliance Management: An Exclusive Interview




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: F. Hoffmann-La Roche: Alliance Management: An Exclusive Interview
Released on: November 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 30 seconds preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F. Hoffmann-La Roche, about his role within the Pharma Partnering Group at Roche. Eric outlines the structure of the Pharma Partnering Group and Roche's overall model for alliance management. The discussion covers Roche's long-term alliance with MorphoSys and the integrated approach that has allowed the companies to harness both science and business, and develop and maintain a successful alliance. Eric also highlights the importance of flexibility in management strategy when assessing alliance candidates and gives an overview of what Roche looks for in a potential partner.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Eric de La Fortelle is Global Head, External Research and Technology, for Roche Pharma Partnering in Basel, Switzerland. He heads a group with a mandate to find and establish contracts, and to manage global alliances with companies offering discovery-stage products and innovative technologies.
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation, and a market leader in virology.